Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study.
Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Prasithsirikul W, Athichathanabadi C, Likanonsakul S, Chaovavanich A. Manosuthi W, et al. Among authors: likanonsakul s. Curr Ther Res Clin Exp. 2008 Feb;69(1):90-100. doi: 10.1016/j.curtheres.2008.02.007. Curr Ther Res Clin Exp. 2008. PMID: 24692786 Free PMC article.
Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.
Manosuthi W, Sungkanuparph S, Thakkinstian A, Rattanasiri S, Chaovavanich A, Prasithsirikul W, Likanonsakul S, Ruxrungtham K. Manosuthi W, et al. Among authors: likanonsakul s. Clin Infect Dis. 2006 Jul 15;43(2):253-5. doi: 10.1086/505210. Epub 2006 Jun 12. Clin Infect Dis. 2006. PMID: 16779754
Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
Manosuthi W, Mankatitham W, Lueangniyomkul A, Thongyen S, Likanonsakul S, Suwanvattana P, Thawornwan U, Suntisuklappon B, Nilkamhang S, Sungkanuparph S; TIME Study Team. Manosuthi W, et al. Among authors: likanonsakul s. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):377-83. doi: 10.1097/QAI.0b013e31825b5e06. J Acquir Immune Defic Syndr. 2012. PMID: 22592586 Clinical Trial.
A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K; N2R Study Team. Manosuthi W, et al. Among authors: likanonsakul s. Clin Infect Dis. 2009 Jun 15;48(12):1752-9. doi: 10.1086/599114. Clin Infect Dis. 2009. PMID: 19438397 Clinical Trial.
Influence of ABCB-1 C3435T polymorphisms on plasma nevirapine and efavirenz levels and their effects on virologic and immunological outcomes in HIV/TB co-infected Thai adults under anti-retroviral therapy.
Uttayamakul S, Likanonsakul S, Manosuthi W, Wichukchinda N, Shioda T, Khusmith S. Uttayamakul S, et al. Among authors: likanonsakul s. Southeast Asian J Trop Med Public Health. 2012 Jan;43(1):78-88. Southeast Asian J Trop Med Public Health. 2012. PMID: 23082557 Clinical Trial.
Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.
Manosuthi W, Van Tieu H, Mankatitham W, Lueangniyomkul A, Ananworanich J, Avihingsanon A, Siangphoe U, Klongugkara S, Likanonsakul S, Thawornwan U, Suntisuklappon B, Sungkanuparph S; N2R Study Team. Manosuthi W, et al. Among authors: likanonsakul s. AIDS. 2009 Nov 27;23(18):2467-71. doi: 10.1097/QAD.0b013e32832f7b59. AIDS. 2009. PMID: 19898217
48 results